Stay updated on SL-401 in BPDCN or AML Clinical Trial
Sign up to get notified when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.

Latest updates to the SL-401 in BPDCN or AML Clinical Trial page
- Check4 days agoChange DetectedResults data and related publications have been added to the study record, including primary and secondary outcomes and survival metrics. Study record dates have been updated to reflect results submission.SummaryDifference0.4%

- Check12 days agoNo Change Detected
- Check33 days agoChange DetectedUpdate to version v3.2.0 and an operating-status notice; removal of a specific medical term and the older version label (v3.1.0).SummaryDifference3%

- Check40 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1; the Back to Top element has been removed.SummaryDifference0.1%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as detailed information on various hematologic neoplasms and skin diseases. Notably, the revision number has been updated to v3.0.0.SummaryDifference2%

Stay in the know with updates to SL-401 in BPDCN or AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.